The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Romidepsin (Brand name: Istodax)
- Manufactured by
Gloucester Pharmaceuticals, Inc.
FDA-approved indication: Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy
National Library of Medicine Drug Information Portal